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2Summary
Spermatogenesis in the adult male depends upon the action of follicle stimulating hormone (FSH)
and androgen. Ablation of either hormone has deleterious effects on Sertoli cell function and the
progression of germ cells through spermatogenesis. In this study we have generated mice lacking
both FSH receptors (FSHRKO) and androgen receptors on the Sertoli cell (SCARKO) to examine
how FSH and androgen interact in the regulation of Sertoli cell function and spermatogenesis.
Sertoli cell number in FSHRKO.SCARKO mice was reduced by about 50% but was not signifi-
cantly different to FSHRKO mice. In contrast, total germ cell number in FSHRKO.SCARKO mice
was reduced to 2% of control mice (and 20% of SCARKO mice) due to a failure to progress beyond
early meiosis. Measurement of Sertoli cell-specific transcript levels showed that half were inde-
pendent of hormonal action on the Sertoli cell while others  were androgen-dependent  or showed
redundant control by FSH and androgen. Results show that there is both synergistic and redundant
regulation of the Sertoli cell and spermatogenesis by FSH and androgen although the Sertoli cell
retains a significant capacity for activity which is independent of direct hormonal regulation.
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Introduction
In the adult animal Sertoli cells act primarily  to promote and maintain germ cell development. This
is achieved by generation of  a unique microenvironment within the seminiferous tubules through
the formation of a Sertoli cell barrier and regulation of solute movement and secretion into the
tubules (Dym and Fawcett 1970; Wong and Cheng 2005). In addition, they  provide cytoarchitec-
tural support and stimulation to the developing germ cells as they undergo proliferation and
differentiation. Previous studies have shown  that spermatogenesis is regulated by follicle-stimulat-
ing hormone (FSH) and testosterone and that these hormones act through specific receptors on the
Sertoli cell (reviewed in (McLachlan et al.,, 2002) ). The role that each of these hormones plays in
the regulation of Sertoli cell function and spermatogenesis has become clearer through study of
mice lacking specific hormones or hormone receptors.  In animals lacking FSH (FSHâKO) or the
FSH receptor (FSHRKO) there is a reduction in Sertoli cell number and germ cell number but the
animals remain fertile (Kumar et al., 1997; Dierich et al., 1998; Abel et al.,, 2000; Johnston et al.,
2004). In contrast, absence of the androgen receptor (AR), either ubiquitously through a mutation in
the receptor (Tfm) or specifically in the Sertoli cells (SCARKO) will cause arrest of spermatogene-
sis in early meiosis (Lyon and Hawkes 1970; De Gendt et al., 2004; Holdcraft and Braun 2004;
3Chang et al., 2004). Thus, FSH appears to act to induce proliferation of the Sertoli cells and germ
cells and to “optimise” the progress of spermatogenesis while testosterone action on the Sertoli cell
is critical for progression through meiosis.
While it is clear that both FSH and androgen are essential for normal spermatogenesis, what
remains unknown is the nature and importance of interaction between the hormones.  For example,
the degree of overlap, or redundancy, is uncertain and also, therefore, the extent to which ablation
of one hormone or its receptor may be compensated by the presence of the other hormone. Similar-
ly, the degree to which Sertoli cell function and germ cell development is independent of direct hor-
monal stimulation remains unclear. To answer these questions directly we have generated mice
lacking both FSHR and AR on the Sertoli cell (FSHRKO.SCARKO) and have determined the sub-
sequent effects on Sertoli cell function and spermatogenesis.
Results
Phenotype
Adult FSHRKO.SCARKO mice were normally masculinised  although testes from the double
knockouts were significantly smaller than  FSHRKO, SCARKO or control mice (Table 1). Seminal
vesicle weights were also significantly smaller in FSHRKO.SCARKO mice (Table 1).
Seminiferous tubule diameter decreased across the groups in the order
control>FSHRKO>SCARKO>FSHRKO.SCARKO with an associated increase in the relative
abundance of interstitial tissue (Fig 1).  As expected from previous studies (Abel et al., 2000;
Dierich et al., 1998; De Gendt et al., 2004),  all stages of spermatogenesis were present in FSHRKO
mice while, in SCARKO mice,  the germ cells entered meiosis but there was apparent loss of pach-
ytene spermatocytes with a marked reduction in the number of secondary spematocytes and with
few round spermatids present (Fig 1). In FSHRKO.SCARKO mice germ cells entered meiosis but
for most cells development stopped at early pachytene with no secondary spermatocytes or round
spermatids apparent (Fig 1).
Morphometric analysis showed that Sertoli cell number in 8-week old FSHRKO.SCARKO
mice was similar to FSHRKO mice and significantly less than control or SCARKO mice (Fig  2).
Sertoli cells in SCARKO mice contained apparent large lipid droplets (not shown) that were  clearly
seen in other groups. The total germ cell number was reduced in FSHRKO and SCARKO mice
compared to control and there was a further marked reduction in FSHRKO.SCARKO mice (Fig 2).
The germ cell/Sertoli cell ratio was reduced, though not markedly, in FSHRKO mice compared to
control. In contrast, in SCARKO mice the germ cell/Sertoli cell ratio was reduced to 10% of control
and in the FSHRKO.SCARKO it was further reduced to 2% of control (Fig 2). Analysis  of germ
cell types in each group showed that spermatogonial numbers were reduced by about 60%  in the
4FSHRKO and FSHRKO.SCARKO mice (Fig 3). Spermatocyte number was also reduced by about
50% in FSHRKO and SCARKO mice but in the combined FSHRKO.SCARKO mouse there was
very limited successful progression into meiosis with spermatocyte numbers reduced to about 4% of
control (Fig 3). The number of round spermatids was reduced to about 40% in the FSHRKO mouse
with very few (<0.5% of control) post-meiotic cells present in the SCARKO mouse and none in the
FSHRKO.SCARKO mouse.
Hormone profile
Serum levels of LH were significantly elevated in FSHRKO mice but were not significantly af-
fected in SCARKO mice. In  FSHRKO.SCARKO mice LH levels were significantly greater than all
other groups (Table 2).  There were no significant differences in serum FSH or testosterone  levels
between groups.
Sertoli cell mRNA levels
To examine Sertoli cell function in the 4 groups the levels of 14 Sertoli cell specific mRNA tran-
scripts were measured by real-time PCR relative to an external control and data normalised for
Sertoli cell number (Johnston et al., 2004) (Fig 4). Six of the transcripts tested (Sox9, Itgb1,Wt1,
Dhh, Trf, Cst12, and Dhh) showed no difference in abundance per Sertoli cell between the 4 groups
(Fig 4A). Of the remaining 8 transcripts, 4 showed a significant alteration in levels related only to
the presence of the AR (Rhox5, Aqp8, Tjp1 and Gata1), one transcript responded to the loss of
either FSHR or AR (Slc38a5) and 3 transcripts (Espn, Msi1 and Slc7a4) showed redundant regula-
tion by both receptors (Fig 4B).
Organ weights in 8 week-old mice
Group Testis (mg)* SV (mg)
Control (n=53)  87.3 ± 1.9a  196 ± 5a
FSHRKO (n=36)  36.9 ± 1.3b  183 ± 6ab
SCARKO (n=65)  20.6 ± 0.4c  190 ± 5a
FSHRKO.SCARKO (n=38) 8.1 ± 0.2d  172 ± 5b
* Groups with different letter superscripts are significantly different
Table 1
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Figure 1
Fig 1 Semithin sections from testes of 8 week old Control, FSHRKO, SCARKO and
FSHRKO.SCARKO mice. The FSHRKO mice contained all stages of spermatogenesis al-
though germ cell number was reduced. In SCARKO mice spermatogenesis progressed
through meiosis but there was progressive loss of pachytene spermatocytes and few secondary
spermatocytes or round spermatids were observed.  In FSHRKO.SCARKO mice the tubules
were of a smaller diameter with large numbers of Sertoli cells (black arrowheads) and smaller
numbers of spermatogonia (red arrowheads). Spermatogonia entered meiosis but development
stopped at early pachytene in most cells (yellow arrowhead). The bar represents 20ìm.
Serum hormone levels in 8 week old animals
Group   Testosterone   LH*       FSH
(pmol/ml) (ng/ml) (ng/ml)
Control  4.2 ± 1.7  0.064 ± 0.012a  35.7 ±  11.1
FSHRKO  5.1 ± 3.5  0.286 ± 0.085b  11.9 ± 3.8
SCARKO  8.5 ± 2.4  0.221 ± 0.065ab 32.6 ± 12.3
FSHRKO.SCARKO 3.0 ± 1.4  0.586 ± 0.086c  17.1 ± 5.46
* Groups with different letter superscripts are significantly different
Table  2
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Figure 4
Levels of Sertoli cell-specific mRNA transcripts in testes from 8 week old control,
FSHRKO, SCARKO and FSHRKO.SCARKO mice. Transcripts levels were measured
relative to an external standard by real-time PCR and corrected for Sertoli cell number as
described in Methods. Results show the mean ± sem of 5 or 6 animals per group. Tran-
scripts in A) showed no significant difference in expression per Sertoli cell between
groups while transcripts in B) showed significant variation. In B) the  groups with differ-
ent letter superscripts are significantly different.
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Generation of the FSHRKO.SCARKO mouse provides us with a base from which to examine how
FSH and androgen act and interact through the Sertoli cell to regulate testicular function. In addi-
tion, it allows us to determine what aspects of Sertoli cell  function are independent of  direct hor-
monal input. The phenotype shows that there is both synergistic and redundant regulation of the
Sertoli cell and spermatogenesis by FSH and androgen but that regulation of a significant number
of Sertoli cell transcripts (and, by implication, Sertoli cell function) is independent of direct hormo-
nal control.
Interactions between the effects of FSH and androgens on testicular function have been
studied previously using models such as the hypophysectomised rat or the hypogonadal (hpg)
mouse which lacks gonadotrophin-releasing hormone (GnRH) with consequent loss of circulating
gonadotrophins (Cattanach et al., 1977).  These models have proved to be extremely valuable in our
understanding of hormonal action in the testis but all suffer limitations. In the hpg, for example,
low  levels of circulating gonadotrophins and intratesticular testosterone remain, albeit at very low
levels, while the testes are cryptorchid because of reduced androgen levels after birth. The germ
cell/Sertoli cell ratio in the hpg mouse is reported to be about 1 (Myers et al., 2005) which is greater
than that in the FSHRKO.SCARKO mouse and may be indicative of the low level hormonal stimu-
lation. The advantage of the FSHRKO.SCARKO mouse, in contrast to other models, is the specifi-
city and totality of the knockout effects. All current data suggests that the FSHR is confined to the
Sertoli cells in the male (Heckert and Griswold 2002; Carpenter et al., 1998) while SCARKO mice
have been generated to lack ARs only in the Sertoli cells  (De Gendt et al., 2004). Thus, the targeted
ablations affect only the Sertoli cells in this double knockout and while there may be knock-on ef-
fects on gonadotrophin levels or androgen production these are not complicating factors since the
Sertoli cells are un-responsive.
 Effectively, the FSHRKO.SCARKO mouse provides a baseline control from which the
direct effects of FSH and androgen on Sertoli cell function can be assessed. Thus, in the SCARKO
mouse the Sertoli cells are stimulated by FSH and not androgen, in the FSHRKO mouse they are
stimulated by androgen and not FSH while in the normal mouse they are exposed to both hormones.
From this perspective it can be seen that the action of FSH is to increase Sertoli cell number, total
germ cell number and the number of germ cells associated with each Sertoli cell. This effect is
achieved by increasing the number of spermatogonia and by enhancing the entry of these cells into
meiosis. In contrast, androgens have no direct effect on Sertoli cell number but cause a marked in-
crease in total germ cell number and, thus, the number of germ cells per Sertoli cell. The principal
effect appears to be through increased entry into meiosis and, crucially, by enabling completion of
meiosis. Together, the hormones have an additive effect on entry   into meiosis but act synergisti-
9cally to stimulate completion of meiosis and entry into spermiogenesis. In addition, it is clear from
the double knockout that germ cells can initiate meiosis without direct hormonal stimulation
through the Sertoli cell, supporting the conclusions of  early in vitro studies (Hofmann  and Dym
2005). The general description of hormone action on spermatogenesis is also consistent with earlier
hormone replacement studies which have shown, for example, that FSH and androgen will increase
or restore spermatocyte number (Haywood et al., 2003; Russell et al., 1993; McLachlan et al., 1995)
while androgens will increase the number of post-meiotic germ cells in the hpg mouse (Singh et al.,
1995; Haywood et al., 2003).
Development of a normal sized cohort of Sertoli cells is of importance for male fertility
since each Sertoli cell can only support a finite  number of germ cells. Previous studies have shown
that both FSH and androgen  can act to regulate the final Sertoli cell number in the adult animal
(Sharpe et al., 2003; Johnston et al., 2004) with studies on the Tfm and ARKO mouse suggesting
that the role of androgen is more critical (Johnston et al., 2004; Tan et al., 2005). Initial studies on
the SCARKO mouse showed, however, that regulation of Sertoli cell number is more complex
since androgen-dependent regulation  does not appear to be through direct effects of androgen on
the Sertoli cell  (Johnston et al., 2004; De Gendt et al., 2004; Tan et al., 2005).  In
FSHRKO.SCARKO mice the number of Sertoli cells was identical to the FSHRKO mouse showing
that only FSH is of importance in terms of direct effects on Sertoli cell proliferation with no syner-
gistic effect of androgen apparent.
 The significant increase in LH levels in FSHRKO mice has been reported previously (Baker
et al., 2003) and attributed to reduced testosterone production by the testis. In FSHRKO.SCARKO
mice the increase in LH was more marked and may be indicative of further dysfunction in the
Leydig cells. Both SCARKO and FSHRKO mice have reduced Leydig cell number (Baker et al.,
2003; De Gendt et al., 2005) and it is possible that the effects are additive in the
FSHRKO.SCARKO mouse although this will require further study.  Circulating testosterone levels
were unchanged in both FSHRKO and FSHRKO.SCARKO but there was high variability between
animals and a  more reliable indicator of androgen levels may be the reduction in weight of the
seminal vesicles in FSHRKO.SCARKO mice.
Despite our enhanced understanding of the role played by FSH and androgens in the regula-
tion of spermatogenesis the cellular mechanisms involved are still in some doubt. It is clear that
FSH can regulate levels of a large number of different mRNA transcripts (Sadate-Ngatchou et al.,
2004a) and the overall effect of FSH may be to increase general Sertoli cell activity and, thereby,
enhance germ cell progression and survival. In contrast, only a relatively small number of Sertoli
cell genes have been shown unequivocally by array studies to be androgen-dependent in a number
of different mouse models (Denolet et al., 2006; O'Shaughnessy et al., 2007; Eacker et al., 2007;
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Sadate-Ngatchou et al., 2004b; Zhou et al., 2005). Somewhat confusingly, there is little overlap of
identified androgen-dependent genes between these studies suggesting that androgen targets vary
depending on the age, endocrine environment or previous hormonal exposure of the animals.
Nevertheless, there is some accumulating evidence to suggest that androgens are required for func-
tional generation of the Sertoli cell barrier and for development of the specialised tubular environ-
ment required for germ cell development (Meng et al., 2005; O'Shaughnessy et al., 2007).  Thus, in
contrast to FSH, androgen  action may be mediated through a relatively small number of  changes
in Sertoli cell gene expression. To examine the effect of ablating both FSHR and AR on Sertoli cell
activity we measured the abundance of 14 mRNA species known to be expressed specifically
within the Sertoli cell population in the adult testis. The 14 transcripts divided into 3 groups, those
showing no response to ablation of either or both receptors, those sensitive to loss of the AR and
those sensitive to loss of both receptors.  The relatively large number of transcripts (~40%) which
were unaffected by loss of hormone responsiveness indicates that a significant proportion of Sertoli
cell activity may be independent of hormone action. In addition, 20% of transcripts  (Espn, Msi1
and Slc7a4) showed a degree of  redundancy between the effects of FSH and androgen. Overall,
therefore, extrapolating from this data it appears likely that a significant   number of Sertoli cell
genes are either hormone independent or are regulated to an extent by both hormones which may
act to ensure an adequate baseline of cell activity  irrespective of fluctuations in hormone levels.
When considering changes in Sertoli cell activity following alterations in hormone or hormone
receptor levels  a possible confounding factor is the effect of germ cell loss on Sertoli cell mRNA
transcript levels (Jonsson et al., 1999; Maguire et al., 1993). All of the transcripts reported in this
study, however, have been shown to be unaffected by germ cell ablation (O’Shaughnessy et al,
submitted).
The transcripts shown in Fig 5 were selected for study largely because they are expressed
specifically in the Sertoli cells and illustrate different aspects of hormonal regulation of the cell.
Nevertheless, the altered expression of some of these transcripts, particularly in the SCARKO and
FSHRKO.SCARKO mice,  offers some further clues to the specific mechanism of hormonal action
on the Sertoli cell. ESPN, for example, is an actin-bundling protein (Bartles et al., 1996) and an
integral part of the ectoplasmic specialisations which are specific to the Sertoli cell and contribute
to the Sertoli cell (blood testis) barrier (Sluka et al., 2006). The marked reduction of Espn levels in
the FSHRKO.SCARKO mouse would be likely to contribute to the overall disruption of the Sertoli
cell barrier seen in the absence of the AR alone (Meng et al., 2005).  The marked loss of Aqp8 tran-
scripts in the SCARKO was surprising since previous array studies have not identified Aqp8 as an-
drogen dependent (Zhou et al., 2005; Denolet et al., 2006; O'Shaughnessy et al., 2007). This
discrepancy may have come about, however,  because earlier array studies used immature testes
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(10d and 20d) and expression of Aqp8 only begins around day 16 in the rat testis (Kageyama et al.,
2001). Loss of Aqp8 in the SCARKO mouse and the pattern of expression of the solute carriers
(Slc7a4 and Slc38a5) in the different groups is further evidence that both FSH and androgens act to
regulate the internal environment of the seminiferous tubules and, thereby, facilitate germ cell de-
velopment (O'Shaughnessy et al., 2007).
This study shows that spermatogenesis is largely dependent upon the action of FSH and
androgen on the Sertoli cell with only the initial onset of meiosis apparently  independent of direct
hormonal regulation. The two hormones can both act to maintain the meiotic germ cell population
but there is an absolute need for androgen to complete meiosis. Spermiogenesis does not appear to
require FSH since the ratio of round spermatids to mature sperm in the FSHRKO is similar to
control (not shown) though the models are not informative on the role of androgen in this process.
Since other cell types in the testis express the AR it is also possible that androgens may have
additional indirect effects on spermatogenesis and this will require further study of
FSHRKO.ARKO mice.
Materials and Methods
Animals and treatments
All mice were bred and all procedures carried out under UK Home Office Licence and with the
approval of a local ethical review committee. Mice with a specific Sertoli cell knockout of the AR
have been previously generated by crossing male mice expressing AMH.Cre (Lecureuil et al., 2002)
with female mice carrying an AR with a floxed exon 2 (ARfl ) (De Gendt et al., 2004).  In order to
produce male mice lacking both FSHR and AR within the Sertoli cell, mice carrying the AMH.Cre
transgene (C57-BL6/SJL)  and mice carrying the ARfl allele (Swiss-Webster/129)  were crossed
with  FSHRKO mice  (C57-BL6/129) and interbred (Abel et al., 2000).  The groups used for com-
parison with the double knockout FSHRKO.SCARKO mice were a) hemizygous FSHRKO/+ males
(FSHRH) expressing AMH.Cre or ARfl which  were considered as control animals (the two groups
were initially analysed separately but no significant difference between the AMH.Cre and ARfl
groups was seen and the data was combined) b) FSHRKO.Cre and FSHRKO.ARfl which were con-
sidered as FSHRKO animals and c) FSHRH.SCARKO animals which were considered as
SCARKO animals for this study. PCR genotyping was carried out as previously described (Hirst et
al., 2004; De Gendt et al., 2004).
Mice were killed at eight weeks and testes snap frozen in liquid nitrogen or fixed overnight.
Fixation was either in Bouin’s for subsequent morphometric analysis or 4% paraformaldehyde/1%
gluteraldehyde in phosphate buffer (0.1M, pH 7.2) for preparation of semi-thin sections.
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Hormone measurements
Blood was collected by cardiac puncture under anaesthesia and the serum separated and stored at
-20oC until assayed. Serum and pituitary levels of FSH and LH were measured commercially using
imunofluorimetric assays (Delfia, Wallac OY, Turku, Finland) as previously described (Haavisto et
al., 1993; van Casteren et al., 2000). Serum levels of testosterone were measured by radioimmu-
noassay following ether extraction (O'Shaughnessy and Sheffield 1990).
Measurement of specific mRNA transcript levels
To quantify the content of specific mRNA species in testes from each group, a real-time PCR
approach was used after reverse transcription (RT) of the isolated RNA. To allow specific mRNA
levels to be expressed per Sertoli cell and to control for the efficiency of RNA extraction, RNA
degradation, and the RT step, an external standard was used (Baker and O'Shaughnessy 2001a;
O'Shaughnessy et al., 2002; Johnston et al., 2004). The external standard was luciferase mRNA
(Promega UK, Southampton, UK), and 5 ng was added to each testis at the start of the RNA
extraction procedure. Testis RNA was extracted using TRIzol (Life Technologies, Paisley, UK) and
the RNA was reverse transcribed using random hexamers and Moloney murine leukemia virus re-
verse transcriptase (Superscript II, Life Technologies, Paisley, UK) as described previously
(O'Shaughnessy and Murphy 1993). For real-time PCR the SYBR green method was used in a 96-
well plate format using a Stratagene MX3000 cycler. Reactions contained 5 ìl 2 x SYBR mastermix
(Stratagene, Amsterdam, Netherlands), primer (100 nM) and template in a total volume of 10 µl. At
the end of the amplification phase a melting curve analysis was carried out on the products formed.
All primers were designed by Primer Express 2.0 (Applied Biosystems, Warrington, UK) using
parameters previously described (Czechowski et al., 2004). The primers used have been described
previously ((O'Shaughnessy et al., 2007) and O’Shaughnessy et al submitted). To correct for Sertoli
cell number data from the real-time PCR studies was divided by the Sertoli cell number of each
group as measured below.
Histology and stereology
To prepare semi-thin (1ìm) sections testes were embedded in araldite and sections stained with
toluidine blue. For stereological analysis, testes were embedded in Technovit 7100 resin, cut into
sections (20ìm), and stained with Harris’ hematoxylin. The total testis volume was estimated using
the Cavalieri principle (Mayhew 1992). The optical disector technique (Wreford 1995) was used to
count the number of Sertoli cells and germ cells in each testis. Each cell type was identified by
previously described criteria (Russell L.D. et al., 1990; Baker and O'Shaughnessy 2001b). The
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numerical density of each cell type was estimated using an Olympus BX50 microscope fitted with a
motorized stage (Prior Scientific Instruments, Cambridge, UK) and Stereologer software (Systems
Planning Analysis, Alexandria, VA, USA).
Statistical analysis
Data was analysed using analysis of variance followed by Fisher’s pairwise comparisons. Data was
log transformed where appropriate to avoid heterogeneity of variance.
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